nav_top

Username:
Password:

Remember Me
Forgot Password

Benefits of Membership
Search By Keyword Or Search By
The Medication Therapy Management of Chronic Obstructive Pulmonary Disease

The Medication Therapy Management of Chronic Obstructive Pulmonary Disease
Please read through the following information and click continue.

ACPE Universal Program Number: 207-000-07-083-H01

Pharmacy CE Release Date: May 23, 2007
Pharmacy CE Expiration Date: May 23, 2010

Case Manager CE Release Date: May 23, 2007
Case Manager CE Expiration Date: May 23, 2008

Statement of Need
In 2003, Chronic Obstructive Pulmonary Disease (COPD) was listed as the fourth leading cause of death in America. In 2004, 11.4 million U.S. adults (aged 18 and over) were estimated to have COPD, costing the nation approximately $37.2 billion in health care expenditures.

Therapies for COPD can only be effective and improve patient outcomes if they are utilized. Studies have shown that adult patients with minimal to moderate airflow limitation who were instructed to utilize bronchodilators three times each day experienced better adherence following study visits. However, adherence with bronchodilators declined in the time between visits. The same study indicated non-adherence is a serious complicating factor in COPD management.

The Medicare Modernization Act brings Medication Therapy Management to the forefront in health care with management of respiratory diseases expressly mentioned in the legislation. Specifically stated, medication therapy management is mandated for targeted high risk beneficiaries, those determined to have multiple chronic disease states, multiple medications, and high drug spend, presenting an opportunity for pharmacists to interact with these at-risk beneficiaries to improve outcomes.

Pharmacists and key team members caring for COPD patients have a huge opportunity to manage the medication therapy of these patients, including counseling and continually reinforcing the importance of adherence to these medicines. Pharmacists and case managers can serve as a conduit for education regarding appropriate dosing and timing of regularly scheduled and as needed medications, the proper technique for inhaled medications, and provide ongoing monitoring and information for family members and caregivers. It is important that pharmacists and case managers are up to date on current COPD recommendations so they can recommend appropriately and provide the most comprehensive COPD medication therapy management possible. According to the 2006 NCPA-Pfizer Digest, community pharmacists discuss drug therapy with prescribers, on average, more than eight times a day.

Learning Objectives
Upon successful completion of this activity, the pharmacist and case manager should be able to:

  • Compare and contrast the clinical features and etiology that differentiate COPD and asthma.
  • Outline management objectives and guidelines for the diagnosis and treatment of COPD.
  • Review current COPD medication regimens including mechanism and onset of action, dosage forms and delivery systems.
  • Discuss lifestyle strategies pharmacists can recommend to their patients to better manage the disease progression of COPD and improve quality of life.
  • Discuss the medication therapy management of COPD patients.

Target Audience
The target market for this activity is pharmacists and case managers.

CE Credit
To receive credit for this activity, you must:

  • Review the full content of the activity and reflect on its teaching.
  • Successfully complete the post-test with a minimum grade of 70% or higher.
  • You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Pharmacists

NCPA® is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 1.5 contact hours (.15 CEUs) of continuing pharmacy education credit under the number 207-000-07-083-H01.


Case Managers

This activity has been approved by the Commission for Case Manager Certification through 5/23/08 for up to 1.50 clock hours of continuing education credit.


Faculty Information
Dennis M. Williams, PharmD

(click on faculty name to view full biography)

Associate Professor Pharmacotherapy and Experimental Therapeutics
UNC School of Pharmacy
Chapel Hill, North Carolina

Faculty Disclosure Statements
Dennis Williams discloses that he has no relevant financial relationships with the program sponsor.

Disclosure Declaration
It is the policy of NCPA® for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest(s) that provide products or services that may be relevant to the content of this continuing medical education activity.

NCPA does not have any relevant financial relationship with any commercial interests related directly or indirectly to the content of this educational activity.

It is the policy of the accreditors to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing medical education activities.


Commercial Support
Commercial Support Provided by Boehringer Ingelheim.




Software Requirements

PC
Windows 2000
Flash Plug-in Player 7.0.1.9
Check my Flash version
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader
Click here to download

MAC
Mac OS 10.2.8
Flash Plug-in Player 7.0.1.9
Check my Flash version
Safari
*Adobe Acrobat Reader
Click here to download

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 

 

 



Select a Profession to Continue: